Hemi-retinal artery occlusion associated with sexual activity and sildenafil citrate (Viagra) [2]

Acta Ophthalmologica Scandinavica

Volumn 81, Issue 2, 2003, Pages 198-200

  Bertolucci, Alessandra ^a   Latkany, Robert A ^a   Gentile, Ronald C ^a,b   Rosen, Richard B ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIHYPERTENSIVE AGENT; CARBOGEN; SILDENAFIL; TIMOLOL MALEATE; VERAPAMIL;

ADULT; CARDIOVASCULAR RISK; CASE REPORT; COLOR VISION DEFECT; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG FATALITY; DRUG MECHANISM; ERECTILE DYSFUNCTION; ESSENTIAL HYPERTENSION; FLUORESCENCE ANGIOGRAPHY; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; LETTER; MALE; PARACENTESIS; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; SEXUAL BEHAVIOR; SYMPTOMATOLOGY; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

CALCIUM CHANNEL BLOCKERS; COITUS; HUMANS; HYPERTENSION; IMPOTENCE; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; RETINAL ARTERY OCCLUSION; VERAPAMIL;

EID: 0038634900     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2003.00044.x     Document Type: Letter

References (4)

1. Arruda-Olson AM, Mahoney DW, Nehra A et al. (2002): Cardiovascular effect of sildenafil during exercise in men with known or probable coronary artery disease. JAMA 287: 719-725.
2. Cheitlin MD, Hutter AM, Brindis RG et al. (1999): Use of sildenafil citrate in patients with cardiovascular disease. Circulation 99: 168-177.
3. National Institutes of Health Consensus Development Panel on Impotence. (1993): Impotence. JAMA 270: 83-90.
4. Porter A, Mager A, Birnbaum Y et al. (1999): Acute myocardial infarction following sildenafil citrate intake in a nitrate free patient. Clin Cardiol 22: 762-763.